Moderate lifetime marijuana smoking not associated with lung function decline
the ONA take:
According to a new study published online in the journal Annals of the American Thoracic Society, researchers at Emory University in Atlanta, Georgia, have found that moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
For the study, researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES). They identified over 5,000 adult survey participants with data on recent marijuana use and respiratory symptoms. Results showed that nearly 60% reported using marijuana at least once during their lifetime, and about 12% said they had used marijuana in the last month.
Among the 3,000 adult participants who had patterns of lifetime marijuana use, cumulative exposure of less than 20 joint-years was not linked with significant changes in lung function; however, more than 20 joint-years of marijuana exposure was associated with clinically significant changes in lung function.
The results do not show whether this change in lung function represents early lung function decline like that of long-term tobacco use. Researchers also found that marijuana smoking increased respiratory irritation, but the study could not determine whether those symptoms were permanent.
The researchers note that they did not assess an association between marijuana use and cancer.
Moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|